Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
The trial aims to evaluate whether the Airvo 3 device in OptiO2 mode can maintain
patients' SpO2 levels within the target range better than manual oxygen titration in
hospitalized COPD patients with hypoxemia/respiratory distress.
Age: 22 years - 66+
Gender: All
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
Recent retrospective studies have demonstrated differences between pulse oximeter values
(SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or
Hispanic. These retrospective studies have limitations because self-reported race is
lik...
Age: Birth - 18 years
Gender: All
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the
Efficacy and Safety of LAM-001 in Adults with Pulmonary Hypertension Associated with
Interstitial Lung Disease (PH-ILD).
Age: 18 - 80 years
Gender: All
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
This is a study to evaluate the efficacy and safety of belzutifan monotherapy in
participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic
neuroendocrine tumor (pNET), von Hippel-Lindau (VHL) disease-associated tumors, advanced
wt (wild-type) gastr...
Age: 12 years - 66+
Gender: All